Trial Profile
Insulin aspart (NovoRapid, Novo Nordisk) vs. human insulin (Actrapid, Novo Nordisk) in intravenous treatment of high blood glucose concentrations in the ICU.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 25 Jul 2011
Price :
$35
*
At a glance
- Drugs Insulin aspart (Primary) ; Insulin
- Indications Hyperglycaemia
- Focus Therapeutic Use
- 25 Jul 2011 New trial record